No takes yet. Share an insight, caveat, or question.
Randomized trial validates Ki-67 staining index as a predictor of distant metastasis and survival in locally advanced prostate cancer, suggesting its use as a clinical biomarker.
Li et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: